Walgreens on Thursday announced plans to close a "significant" number of underperforming stores across the U.S. due to ongoing challenges with profitability and declining margins. The store closures are part of the company's multi-year footprint optimization program. While Walgreens didn't specify how many of its more than 8,700 stores will be affected, CEO Tim Wentworth told The Wall Street Journal that a "meaningful percent" of the underperforming locations would shutter. Walgreens shares tumbled in pre-m ...

Walgreens Boots Alliance (WBA) came out with quarterly earnings of $0.63 per share, missing the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $1 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -5.97%. A quarter ago, it was expected that this largest U.S. drugstore chain would post earnings of $0.82 per share when it actually produced earnings of $1.20, delivering a surprise of 46.34%.Over the last f ...

Update on strategic review Exhibit 99.1 Walgreens Boots Alliance Reports Fiscal 2024 Third Quarter Results Lowering Guidance in Continued Challenging Environment; Provides Strategic Update Third quarter financial highlights Fiscal 2024 guidance 1 • Lowering fiscal 2024 adjusted EPS** guidance to $2.80 to $2.95 reflecting challenging pharmacy industry trends and a worse-than- expected U.S. consumer environment DEERFIELD, Ill. — June 27, 2024 — Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced fina ...

Walgreens logo is seen on a truck semitrailer in Florida Keys, United States on May 7, 2024. (Photo ... [+] by Jakub Porzycki/NurPhoto via Getty Images)NurPhoto via Getty ImagesWalgreens (NASDAQ: WBA) is scheduled to report its fiscal Q3 2024 results on Thursday, June 27 (Walgreens’ fiscal ends in August). We expect WBA stock to trade higher post the Q3 announcement, with its revenue and earnings expected to be above the street estimates. The company will likely benefit from its cost reduction actions, but ...

In its upcoming report, Walgreens Boots Alliance (WBA) is predicted by Wall Street analysts to post quarterly earnings of $0.68 per share, reflecting a decline of 32% compared to the same period last year. Revenues are forecasted to be $35.96 billion, representing a year-over-year increase of 1.6%.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.3% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projecti ...

The market expects Walgreens Boots Alliance (WBA) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended May 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on June 27, 2024, might help the stock move higher if these key numbe ...

The most recent trading session ended with Walgreens Boots Alliance (WBA) standing at $15.55, reflecting a +0.65% shift from the previouse trading day's closing. This change outpaced the S&P 500's 0.04% loss on the day. Elsewhere, the Dow lost 0.15%, while the tech-heavy Nasdaq added 0.12%.The largest U.S. drugstore chain's stock has dropped by 15.76% in the past month, falling short of the Retail-Wholesale sector's gain of 0.37% and the S&P 500's gain of 4.15%.Analysts and investors alike will be keeping a ...

Walgreens stock can't seem to get out of its tailspin.Sometimes it can seem like a stock is a falling knife, where trying to slow its fall is just going to cut you. That's what Walgreens Boots Alliance (WBA -2.45%) investors may be feeling right now. The stock has dropped to levels it hasn't traded at since the 1990s, and it keeps falling lower. The price drop suggests that the market knows that Walgreens faces a tough road ahead.Walgreens is working to regain the market's confidence. With a new CEO, there' ...

In the latest trading session, Walgreens Boots Alliance (WBA) closed at $15.94, marking a +0.63% move from the previous day. The stock's change was more than the S&P 500's daily gain of 0.26%. Meanwhile, the Dow gained 0.18%, and the Nasdaq, a tech-heavy index, added 0.35%.Shares of the largest U.S. drugstore chain witnessed a loss of 7.85% over the previous month, trailing the performance of the Retail-Wholesale sector with its loss of 0.54% and the S&P 500's gain of 3.25%.The investment community will be ...

文章核心观点 Walgreens支持的CityMD将支付1204万美元解决美国司法部提出的新冠欺诈指控 [1] 事件详情 - 2020年2月至2022年4月 该紧急护理提供商涉嫌通过向专门为未参保患者设立的新冠项目提交虚假索赔 骗取政府新冠检测报销款 即便患者有医疗保险 [1] - 新泽西州联邦检察官办公室根据《虚假索赔法》提出指控 该法律通过向举报人提供政府胜诉所得的一部分 鼓励他们对潜在欺诈行为提起诉讼 [1] 举报人情况 - 2020年 CityMD患者Stephen Kitzinger最初指控该欺诈行为 作为将此案告知政府的奖励 他将从和解金中获得超200万美元 [2] 公司应对措施 - CityMD在纽约和新泽西运营着超100家无需预约的紧急护理诊所 该公司配合了政府调查 并聘请第三方公司协助政府确定因涉嫌欺诈造成的损失金额 [2] 官方表态 - 美国检察官Philip R. Sellinger表示 不能也不会容忍对紧急资金项目资金的滥用 [2] 相关方回应 - Walgreens未立即回应非工作时间发出的置评请求 [2]